3Z Pharmaceuticals Unveils Landmark Study Supporting Calcium Channel Blocker as a Groundbreaking ADHD Therapy
REYKJAVIK,Iceland,Feb. 17,2025-- 3Z Pharmaceuticals today announced the publication of a transformative study in Neuropsychopharmacology,highlighting compelling scientific evidence that positions the